Literature DB >> 20208009

The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases.

Gang Liu1, Catherine L Atteridge, Xuanjun Wang, Ashley D Lundgren, Jennifer D Wu.   

Abstract

Engagement of tumor cell surface MHC class I chain-related molecule A (MICA) to NKG2D stimulates NK and T cell antitumor immunity. Shedding of MICA by tumor cells facilitates tumor immune evasion, which may in part contribute to tumor progression. Thus, elucidating the mechanisms by which tumors shed MIC is of great importance for therapy to reinforce NK and T cell antitumor immunity. In this study, we report that the membrane type matrix metalloproteinase (MMP)14 mediates MICA shedding. Suppression of MMP14 expression blocks MICA shedding. Concomitantly, overexpression of MMP14 enhances MICA shedding. The regulation of MICA shedding by MMP14 is independent of the activity of a disintegrin and metalloproteinases, which have been reported to mediate MICA shedding. Finally, MMP14 expression in MICA-positive tumor cells regulates the sensitivity of tumor cells to NK cell killing. These findings suggest that MMP14 may be a new target for tumor immune therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20208009      PMCID: PMC3191873          DOI: 10.4049/jimmunol.0903789

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Protein ectodomain shedding.

Authors:  Joaquín Arribas; Aldo Borroto
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

2.  The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1.

Authors:  Gabriela Velasco-Loyden; Joaquín Arribas; Fernando López-Casillas
Journal:  J Biol Chem       Date:  2003-12-12       Impact factor: 5.157

3.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

Authors:  Veronika Groh; Jennifer Wu; Cassian Yee; Thomas Spies
Journal:  Nature       Date:  2002-10-17       Impact factor: 49.962

4.  Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Authors:  V Groh; R Rhinehart; J Randolph-Habecker; M S Topp; S R Riddell; T Spies
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

5.  Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.

Authors:  Helmut R Salih; Hans-Georg Rammensee; Alexander Steinle
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

6.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.

Authors:  Douglas A Rubinson; Christopher P Dillon; Adam V Kwiatkowski; Claudia Sievers; Lili Yang; Johnny Kopinja; Dina L Rooney; Mingdi Zhang; Melanie M Ihrig; Michael T McManus; Frank B Gertler; Martin L Scott; Luk Van Parijs
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

7.  Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

Authors:  Ekaterina S Doubrovina; Mikhail M Doubrovin; Elena Vider; Richard B Sisson; Richard J O'Reilly; Bo Dupont; Yatin M Vyas
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

Review 8.  Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.

Authors:  Renaud Poincloux; Floria Lizárraga; Philippe Chavrier
Journal:  J Cell Sci       Date:  2009-09-01       Impact factor: 5.285

9.  T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells.

Authors:  Jennifer Wu; Veronika Groh; Thomas Spies
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

Review 10.  Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP).

Authors:  Pamela Osenkowski; Marta Toth; Rafael Fridman
Journal:  J Cell Physiol       Date:  2004-07       Impact factor: 6.384

View more
  51 in total

1.  Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.

Authors:  A Baragaño Raneros; V Martín-Palanco; A F Fernandez; R M Rodriguez; M F Fraga; C Lopez-Larrea; B Suarez-Alvarez
Journal:  Genes Immun       Date:  2014-11-13       Impact factor: 2.676

Review 2.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

Review 3.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

4.  A2A Adenosine Receptor Gene Deletion or Synthetic A2A Antagonist Liberate Tumor-Reactive CD8+ T Cells from Tumor-Induced Immunosuppression.

Authors:  Jorgen Kjaergaard; Stephen Hatfield; Graham Jones; Akio Ohta; Michail Sitkovsky
Journal:  J Immunol       Date:  2018-05-25       Impact factor: 5.422

5.  Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis.

Authors:  Gang Liu; Shengjun Lu; Xuanjun Wang; Stephanie T Page; Celestia S Higano; Stephen R Plymate; Norman M Greenberg; Shaoli Sun; Zihai Li; Jennifer D Wu
Journal:  J Clin Invest       Date:  2013-09-09       Impact factor: 14.808

6.  Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.

Authors:  Shengjun Lu; Jinyu Zhang; Dai Liu; Guangfu Li; Kevin F Staveley-O'Carroll; Zihai Li; Jennifer D Wu
Journal:  Clin Cancer Res       Date:  2015-06-23       Impact factor: 12.531

7.  Inhibition of Granzyme B by PI-9 protects prostate cancer cells from apoptosis.

Authors:  Manisha Ray; Daniel R Hostetter; Carly R K Loeb; Jeffry Simko; Charles S Craik
Journal:  Prostate       Date:  2011-09-14       Impact factor: 4.104

Review 8.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

Review 9.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

10.  NKG2D Ligands in Cancer Immunotherapy: Target or Not?

Authors:  Jennifer Wu
Journal:  Austin J Clin Immunol       Date:  2014-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.